Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Executive summary The 2024 update of the Lancet Commission on dementia provides new
hopeful evidence about dementia prevention, intervention, and care. As people live longer …
hopeful evidence about dementia prevention, intervention, and care. As people live longer …
Alzheimer's disease–why we need early diagnosis
J Rasmussen, H Langerman - Degenerative neurological and …, 2019 - Taylor & Francis
Alzheimer's disease is the leading cause of dementia. However, neither Alzheimer's disease
nor Alzheimer's dementia are an inevitable consequence of aging. This review provides an …
nor Alzheimer's dementia are an inevitable consequence of aging. This review provides an …
Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges
Background: Timely diagnosis of Alzheimer's disease (AD) refers to a diagnosis at the stage
when patients come to the attention of clinicians because of concerns about changes in …
when patients come to the attention of clinicians because of concerns about changes in …
The global prevalence of dementia: a systematic review and metaanalysis
BACKGROUND: The evidence base on the prevalence of dementia is expanding rapidly,
particularly in countries with low and middle incomes. A reappraisal of global prevalence …
particularly in countries with low and middle incomes. A reappraisal of global prevalence …
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
Background Depression is common in dementia but the evidence base for appropriate drug
treatment is sparse and equivocal. We aimed to assess efficacy and safety of two of the most …
treatment is sparse and equivocal. We aimed to assess efficacy and safety of two of the most …
[HTML][HTML] The economic burden of dementia in China, 1990–2030: implications for health policy
J Xu, J Wang, A Wimo, L Fratiglioni… - Bulletin of the World …, 2017 - ncbi.nlm.nih.gov
Objective To quantify and predict the economic burden of dementia in China for the periods
1990–2010 and 2020–2030, respectively, and discuss the potential implications for national …
1990–2010 and 2020–2030, respectively, and discuss the potential implications for national …
PET neuroimaging of Alzheimer's disease: radiotracers and their utility in clinical research
W Bao, F Xie, C Zuo, Y Guan… - Frontiers in aging …, 2021 - frontiersin.org
Alzheimer's Disease (AD), the leading cause of senile dementia, is a progressive
neurodegenerative disorder affecting millions of people worldwide and exerting tremendous …
neurodegenerative disorder affecting millions of people worldwide and exerting tremendous …
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase …
A Leuzy, NJ Ashton, N Mattsson-Carlgren… - European journal of …, 2021 - Springer
Purpose In the last decade, the research community has focused on defining reliable
biomarkers for the early detection of Alzheimer's disease (AD) pathology. In 2017, the …
biomarkers for the early detection of Alzheimer's disease (AD) pathology. In 2017, the …
Applications of biosensors in Alzheimer's disease diagnosis
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive
and irreversible cognitive decline. Currently, it affects 36 million people and due to …
and irreversible cognitive decline. Currently, it affects 36 million people and due to …
Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations
D Brooker, JL Fontaine, S Evans… - International journal of …, 2014 - Wiley Online Library
Objective ALzheimer's COoperative Valuation in Europe (ALCOVE) was a Joint Action co‐
financed by the European Commission to produce a set of evidence‐based …
financed by the European Commission to produce a set of evidence‐based …